There have been diverse perspectives and activities revolving around Corteva (CTVA). Intense institutional interest has been recorded, with organizations such as Allstate Corp, Teacher Retirement System of Texas, and New York State Teachers Retirement System purchasing shares. CTVA's shares are also being boosted by several entities, including Robeco Institutional Asset Management B.V., and Fjarde AP Fonden Fourth Swedish National Pension Fund.
However, there have been instances of stakes being sold, exemplified by Massachusetts Financial Services Co. MA and Sumitomo Mitsui Trust Group Inc.
Citigroup has revised the price target to $74, maintaining its neutral rating, while J.P. Morgan retains an overweight stance, raising the price target to $75. This has been echoed and surpassed by Mizuho, setting the new target at $80.
A notable development includes the launch of the Telbek PRO fungicide by CTVA, which strives to tackle wheat disease.
CTVA's collaboration with bp on the Etlas Biofuels JV can't be overlooked. Also, its crop protection pact, business split proposal, and Hexagon Bio partnership indicate a robust strategy.
Despite facing a dip after the split proposal, Corteva later saw a rise in its share price, suggesting a bounce-back capacity.
Corteva CTVA News Analytics from Tue, 29 Jul 2025 07:00:00 GMT to Sat, 24 Jan 2026 22:09:26 GMT - Rating 5 - Innovation 4 - Information 7 - Rumor -1
